Belite Bio, Inc

Contributing Author

Recent Articles by Belite Bio, Inc

Jul-02	Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy BLTE GlobeNewswire
May-21	Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease BLTE GlobeNewswire
May-13	Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update BLTE GlobeNewswire
May-12	Belite Bio to Participate in Four Upcoming Investor Conferences BLTE GlobeNewswire
May-07	Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results BLTE GlobeNewswire